TABLE 3.
Risk factors for recurrence of atrial fibrillation (AF) by multivariate Cox regression analysis model.
Variable | Model 3 |
Model 4 |
||
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Hypertension | 1.22 (0.82∼1.81) | 0.336 | 1.29 (0.86∼1.92) | 0.219 |
Duration of AF (≥3 years) | 1.54 (1.08∼2.18) | 0.017 | 1.48 (1.04∼2.11) | 0.032 |
Persistent AF | 1.56 (1.10∼2.20) | 0.012 | 1.46 (1.03∼2.07) | 0.035 |
LAD | 1.06 (1.03∼1.09) | <0.001 | 1.06 (1.03∼1.09) | <0.001 |
CHA2DS2-VASc score | 1.05 (0.95∼1.17) | 0.357 | 1.06 (0.92∼1.22) | 0.443 |
BMI | 1.03 (0.97∼1.08) | 0.368 | ||
Age | 1.00 (0.98∼1.03) | 0.976 | ||
FIB-4, continuous variable | 1.24 (1.12∼1.38) | <0.001 | ||
NFS, continuous variable | 1.28 (1.07∼1.52) | 0.008 |
Model 3 included hypertension, duration of AF (≥3 years), persistent AF, LAD, CHA2DS2-VASc score, BMI, and FIB-4; Model 4 included hypertension, duration of AF (≥3 years), persistent AF, LAD, CHA2DS2-VASc score, age, and NFS. The variables in the liver fibrosis score formula were not enrolled in the multivariate Cox analysis model. AF, atrial fibrillation; LAD, left atrial diameter; BMI, body mass index; FIB-4, fibrosis-4; NFS, non-alcoholic fatty liver disease fibrosis score; HR, hazard ratio; CI, confidence interval.